Table 4. Prevalence of 3GCr and carbapenem-resistant pathogens among patients with community-acquired UTI.
Covariates* | 3GCr n (%) | Age (yrs) (Mean±SD) | OR (CI) | Covariates* | CarbR n (%) | Age (yrs) (Mean±SD) | OR (CI) |
---|---|---|---|---|---|---|---|
Adult (n = 521) | Adult (n = 521) | ||||||
Male (n = 107) | 77 (72) | 58.88±12.97 | 1 | Male (n = 107) | 5 (5) | 62.40±7.64 | 1 |
Female (n = 414) | 271 (65) | 53.27±14.17 | 0.74 (0.46–1.18) | Female (n = 414) | 20 (5) | 53.15±16.58 | 1.04 (0.38–2.83) |
Adolescent (n = 8) | Adolescent (n = 8) | ||||||
Male (n = 2) | 1 (50) | - | 1 | Male (n = 2) | 1 (50) | - | - |
Female (n = 6) | 4 (67) | 14.00±3.46 | 2 (0.07–51.59) | Female (n = 6) | 0 | - | - |
Child (n = 58) | Child (n = 58) | ||||||
Male (n = 21) | 15 (71) | 2.00±1.85 | 1 | Male (n = 21) | 2 (10) | 1.23±0.86 | 1 |
Female (n = 37) | 24 (65) | 4.67±3.03 | 0.74 (0.23–2.36) | Female (n = 37) | 2 (5) | 8±1.41 | 0.54 (0.07–4.17) |
CarbR, carbapenem resistant; n, number; 3GCr, 3rd generation cephalosporin resistant
*One isolate represents one patient. A total of 587 Gram-negative isolates were tested for susceptibility against third-generation cephalosporin and carbapenem antibiotics.